Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...

Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...

Pharmacists say they are aware of people being wrongly prescribed the drugs who have previously had eating disorders, or ...

Hugely popular weight-loss jabs like Wegovy have been making headlines for enabling people to manage diabetes and excess weight along with other benefits, scientists say.Increasingly recommended by ...

The pharmacy association said it was worried some patients were accessing the drugs inappropriately amid a surge in demand.View on euronews ...

If you're struggling to maintain your weight, there are options available that can help. Calocurb is a natural appetite ...

Health experts have issued a new warning about the online sale of weight-loss jabs.The focus of these fresh updates were the ...

Britain’s pharmacists have called for tougher regulation of weight-loss drugs after reports showed some online sellers have set targets for clinicians to process more than 20 patients every hour.

Weight-loss jabs, known as GLP-1 receptor agonists, work by reducing food cravings. The NPA has previously urged patients to ...

Pharmacy leaders have issued a warning over the online sale of weight-loss jabs insisting there is still a risk to patient ...